This is a publication that EPI-Q assisted with

Authors:
Lisa R. Rogers, DO
Sandra E. Remer, RN
Sheela Tejwani, MD

Abstract:

We report a durable (12 months) clinical, MRI, and cerebrospinal fluid response to capecitabine monotherapy in a patient with leptomeningeal metastasis from breast cancer.